Litcius/Paper detail

Dupilumab Demonstrates Rapid Onset of Response Across Three Type 2 Inflammatory Diseases

Giorgio Walter Canonica, Arnaud Bourdin, Anju T. Peters, Martin Desrosiers, Claus Bachert, Stephan Weidinger, Eric L. Simpson, Nadia Daizadeh, Zhen Chen, Siddhesh Kamat, Asif Khan, Jingdong Chao, Neil M.H. Graham, Elizabeth Laws, Ana B. Rossi, Marius Ardeleanu, Leda Mannent, Nikhil Amin, Benjamin Ortiz, Yamo Deniz, Michel Djandji, Paul J. Rowe

2022The Journal of Allergy and Clinical Immunology In Practice53 citationsDOIOpen Access PDF

Topics & Concepts

MedicineDupilumabEczema Area and Severity IndexDermatology Life Quality IndexAtopic dermatitisAsthmaPlaceboInternal medicineQuality of life (healthcare)Severity of illnessBronchodilatorGastroenterologyDermatologyDiseasePathologyNursingAlternative medicineSinusitis and nasal conditionsAllergic Rhinitis and SensitizationDermatology and Skin Diseases
Dupilumab Demonstrates Rapid Onset of Response Across Three Type 2 Inflammatory Diseases | Litcius